2 impressive ASX shares that could be buys in November 2021

Lovisa and Healthia are two ASX shares that could be contenders this month
The post 2 impressive ASX shares that could be buys in November 2021 appeared first on The Motley Fool Australia. –

This month could be the perfect time to look at two ASX shares that may generate significant growth in FY22 and beyond.

Both of these companies are smaller than the ASX blue chips like Australia and New Zealand Banking Group Ltd (ASX: ANZ) and BHP Group Ltd (ASX: BHP). However, they may have the ability to produce more capital growth because of their smaller starting size.

Lovisa Holdings Ltd (ASX: LOV)

This is a business that sells affordable jewellery to customers.

It has more than 500 stores across the world. While the biggest number (153 at the end of FY21) is in Australia, it has growing store networks in Europe, Asia, the Middle East, South Africa, the UK, and the USA. COVID-19 caused disruption to growth, but the company has plans to continue the rollout. The Beeline acquisition helped with the expansion into Europe, with 87 stores converted to Lovisa branding.

FY21 demonstrated rising profitability at various levels of the business. Revenue grew 18.9% to $288 million, pre AASB16 earnings before interest and tax (EBIT) increased 39.4% to $42.7 million, and net profit after tax (NPAT) grew by 43.3% to $27.7 million. The company also returned to paying a dividend.

In the first eight weeks of FY22, the ASX share saw that total sales were up 56% year on year, despite lockdowns in some locations.

While 2021 calendar year store opening growth is expected to be slowed due to logistics challenges, it’s focused on opportunities for increasing its store network and its digital presence. It currently has 551 stores.

The broker Morgan Stanley thinks the company is a buy. It believes the Lovisa share price is valued at 36x FY23’s estimated earnings.

Healthia Ltd (ASX: HLA)

As the name may suggest, Healthia is a healthcare business. It is aiming to build Australia’s leading diversified healthcare business across the divisions of ‘bodies and minds’, ‘feet and ankles’, and ‘eyes and ears’.

The company has a two-pronged approach to achieve growth.

The first is with its organic growth. It says its model has demonstrated the ability to accelerate organic growth as a result of a focus and investment in industry-leading education, tools, and support for clinicians and team members. In FY20 it achieved organic revenue growth of 5.3% and in FY21 it was 9.1%.

The second area of growth is the ASX share’s acquisitions to expand and diversify its operations. Part of that strategy is to use ‘clinic class shares’ to retain and incentivise clinicians. These shares are non-voting but entitle the holder to a share of any dividend declared.

One of the latest acquisitions has been Back in Motion (BIM) for a total cost of $88.4 million, being $64.6 million in cash and $16.1 million of clinic class shares, as well as $5.8 million of new shares and $1.9 cash payable after completion of the acquisition. BIM is one of the largest and fastest-growing physiotherapy businesses in Australia and New Zealand.

The BIM deal made Healthia the No. 1 provider of physiotherapy services in Australia with a total of 122 physiotherapy clinics. In FY21, BIM generated underlying revenue of $62.9 million and underlying earnings before interest, tax, depreciation, and amortisation (EBITDA) of $12.3 million respectively.

In FY21, the Healthia business reported underlying revenue growth of 51.8% to $140.41 million and underlying EBITDA of $21.47 million (up 62.3%). Underlying net profit grew 91.4% to $8.86 million. The ASX share also paid a full-year dividend of 4.5 cents per share.

The post 2 impressive ASX shares that could be buys in November 2021 appeared first on The Motley Fool Australia.

Should you invest $1,000 in Lovisa right now?

Before you consider Lovisa, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Lovisa wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

More reading

Lovisa (ASX:LOV) share price falls on surprise CEO exit

2 compelling ASX shares that could be buys in October 2021

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!